Hemangioma in Infants: Understanding Causes, Potential Problems, and Remedies
Infantile hemangioma, a benign tumor of vascular nature, is estimated to affect nearly 5% of all babies, making it the most common among infants. This condition forms along endothelial cells and can manifest in numerous parts of the body.
The most common form of infantile hemangioma is the superficial (capillary) type, which appears as bright red birthmarks and most commonly manifests on the head and neck region. These superficial hemangiomas develop closer to the skin and can grow rapidly in the first 7-12 weeks. In contrast, deep hemangiomas develop deeper and can manifest on nerves, organs, or muscles, potentially causing symptoms such as abdominal pain, nausea, loss of appetite, excessive vomiting, inflated abdomen, and extreme weight loss.
Doctors may use ultrasonography, MRI, or CT scan for diagnostic purposes. In some cases, ulceration on the hemangioma surface can occur before visible symptoms appear, causing pain to the baby. For treating ulcers on the surface of hemangiomas, a medicated gel containing becaplermin is used, while beta-blockers are used as a topical treatment for small, superficial hemangiomas.
Corticosteroid medication is often the first treatment step for infantile hemangioma, with Propranolol being a common corticosteroid drug. However, for larger or sensitive areas like the eye, surgery may be recommended. Laser treatment is also common for hemangioma removal and promotes quick healing.
It is essential to consult a primary physician for treatment and follow their instructions. Combining holistic medication with traditional medication is not recommended without consulting a doctor first. Complications associated with hemangioma in infants can include interference with organ function and ulceration, which can harm the baby's overall health if left untreated.
Research suggests that hemangiomas may run in families, but this has not been conclusively proven. Mixed hemangiomas are a combination of both superficial and deep hemangiomas. Hemangiomas are not associated with actions taken or not taken during pregnancy.
Hemangiomas rarely are associated with Neurocutaneous syndrome and other underlying conditions. Scarring due to hemangioma depends on the location and size of the lesion. It is important to note that hemangiomas can cause bleeding in rare cases.
In conclusion, while infantile hemangioma is a common condition in infants, it is crucial to seek medical advice promptly to ensure proper treatment and minimise potential complications. By understanding the signs, symptoms, and available treatments, parents can take proactive steps to manage this condition effectively.
